Could a common antiviral drug save lives in advanced HIV?
Disease control
Not yet recruiting
This study tests whether valganciclovir, a drug that stops CMV from multiplying, can safely lower CMV levels in the blood of people with advanced HIV. About 130 adults and adolescents with very weak immune systems will receive either the drug or a placebo daily for 4 weeks, while…
Phase: PHASE2 • Sponsor: Wits Health Consortium (Pty) Ltd • Aim: Disease control
Last updated May 12, 2026 13:40 UTC